コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ailure (low/normal testosterone and elevated luteinizing hormone).
2 and lower levels of endogenous estradiol and luteinizing hormone.
3 gesterone, follicle-stimulating hormone, and luteinizing hormone.
4 iosynthesis before the preovulatory surge of luteinizing hormone.
5 d all had abnormal secretion of GnRH-induced luteinizing hormone.
6 in a significant decrease in serum levels of luteinizing hormone.
7 ted by the downstream pulsatile secretion of luteinizing hormone.
8 e, thereby inhibiting the proestrus surge in luteinizing hormone.
9 Ratios of follicle stimulating hormone to luteinizing hormone, a sexual maturity indicator, in all
10 r GalNAc to N-linked oligosaccharides on the luteinizing hormone alpha subunit and CA6 but not to tho
11 We measured follicle-stimulating hormone and luteinizing hormone and added information on menstrual p
13 A limited number of glycoproteins including luteinizing hormone and carbonic anhydrase-VI (CA6) bear
14 yp2j5 (-/-) mice, but their plasma levels of luteinizing hormone and follicle stimulating hormone wer
16 d equally well to the stimulatory actions of luteinizing hormone and follicle-stimulating hormone and
17 ce also have decreased circulating levels of luteinizing hormone and follicle-stimulating hormone but
20 pulsatile release of gonadotropin hormones (luteinizing hormone and follicle-stimulating hormone) fr
21 gent induced high levels of the gonadotropin luteinizing hormone and increased the serum concentratio
22 e time course or the plasma concentration of luteinizing hormone and its physiological effects on the
23 -releasing hormone (GnRH) induces a surge of luteinizing hormone and ovulation in a variety of specie
27 restores gonadotrophin secretion, as well as luteinizing hormone and thyroid-stimulating hormone puls
29 sisting of an alpha subunit, also present in luteinizing hormone, and a unique beta subunit, which is
30 ormones: human chorionic gonadotropin, human luteinizing hormone, and follicle stimulating hormone by
32 erum levels of CRP, estradiol, progesterone, luteinizing hormone, and follicle-stimulating hormone we
33 droepiandrosterone (DHEAS), androstenedione, luteinizing hormone, and follicle-stimulating hormone.
34 d levels of follicle-stimulating hormone and luteinizing hormone, and increased variability of estrad
37 l follicles, independently of an increase in luteinizing hormone, and this phenotype can be reversed
38 nadotropins follicle-stimulating hormone and luteinizing hormone are heterodimeric glycoproteins expr
39 estradiol, follicle-stimulating hormone, and luteinizing hormone around the woman's own mean levels w
41 hether MIP-2A can transcriptionally regulate luteinizing hormone beta (LHbeta), a pituitary-specific
42 riptional activation of both the FSHbeta and luteinizing hormone beta subunit (LHbeta) gene promoters
44 utant mouse, whereas proopiomelanocortin and luteinizing hormone beta-subunit expression were normal
46 2 binding to the active but unphosphorylated luteinizing hormone/choriogonadotropin receptor (LH/CG R
47 hat agonist-dependent desensitization of the luteinizing hormone/choriogonadotropin receptor (LH/CG R
48 ine 3 (Org 41841), a partial agonist for the luteinizing hormone/choriogonadotropin receptor (LHCGR)
52 identified previously as an agonist for the luteinizing hormone/chorionic gonadotropin receptor (LHC
53 mical analysis colocalized expression of the luteinizing hormone/chorionic gonadotropin receptor, PRO
55 energy, vitamin E intake, physical activity, luteinizing hormone, follicle-stimulating hormone, and p
56 nophore-induced acrosome reaction as well as luteinizing hormone, follicle-stimulating hormone, and t
58 ycle arrested at prophase of meiosis I until luteinizing hormone from the pituitary acts on the folli
59 onding with an increase in expression of the luteinizing hormone gene, Lhb We demonstrate that poorly
62 third transmembrane alpha-helix (TM3) of the luteinizing hormone/human chorionic gonadotropin recepto
66 es the interictal and postictal secretion of luteinizing hormone in mesial temporal lobe epilepsy.
69 one administration results in suppression of luteinizing hormone in wild-type male mice, but paradoxi
70 ed puberty associated with low or apulsatile luteinizing hormone) in both humans and in the mouse mod
71 arcuate nucleus, and a reduced compensatory luteinizing hormone increase compared with control anima
72 er (13.4+/-3.2 nmol per liter, P<0.001), the luteinizing hormone level increased from 2.7+/-2.0 to 8.
73 one, follicle-stimulating hormone level, and luteinizing hormone level were measured and testicular h
74 had higher follicle-stimulating hormone and luteinizing hormone levels and lower estradiol levels at
75 e mean (SE) follicle-stimulating hormone and luteinizing hormone levels decreased to 8.6 (0.4) mIU/mL
76 , E1, E1S, follicle-stimulating hormone, and luteinizing hormone levels in all patients and the propo
77 ale mice, but paradoxically stimulates serum luteinizing hormone levels in GPRC6A(-/-) null mice.
78 estrous cycles and elevated testosterone and luteinizing hormone levels, suggesting altered hypothala
82 s thought to be indirectly controlled by the luteinizing hormone (LH) acting through the LH/choriogon
83 Meiosis in mammalian oocytes is paused until luteinizing hormone (LH) activates receptors in the mura
86 with consequent diminished levels of plasma luteinizing hormone (LH) and correspondingly attenuated
87 esis and secretion of gonadotropic hormones, luteinizing hormone (LH) and follicle stimulating hormon
88 osynthesis and release of the gonadotropins, luteinizing hormone (LH) and follicle stimulating hormon
89 ith gonadotropic endocrine cells [expressing luteinizing hormone (LH) and follicle-stimulating hormon
91 close to follicle-stimulating hormone (FSH), luteinizing hormone (LH) and growth hormone (GH) cells.
94 of gonadotropin releasing hormone (GnRH) and luteinizing hormone (LH) are pivotal events in female re
96 oma cells were treated with the gonadotropin luteinizing hormone (LH) at concentrations equivalent to
98 serum follicle-stimulating hormone (FSH) and luteinizing hormone (LH) clearly separated hypogonadotro
99 validate AutoDecon for application to serum luteinizing hormone (LH) concentration time series using
101 (GNRH)-stimulated synthesis and secretion of luteinizing hormone (LH) from the pituitary gonadotroph.
102 ating follicle-stimulating hormone (FSH) and luteinizing hormone (LH) gene expression in the pituitar
103 inhibited the kisspeptin-induced release of luteinizing hormone (LH) in rats and mice and blocked th
105 and then augments (positive feedback) serum luteinizing hormone (LH) increased Kiss1 mRNA density an
110 along with minimal repression of circulating luteinizing hormone (LH) levels and no change in the lip
113 etion of GnRH is also reduced as basal serum luteinizing hormone (LH) levels were significantly lower
114 he fabrication of a nanosensor for detecting luteinizing hormone (LH) of sheep using a gold nanoparti
117 Adult obesity is associated with blunted luteinizing hormone (LH) pulse amplitude that is partial
118 fertility, is associated with an increase in luteinizing hormone (LH) pulse frequency, implicating ab
120 eavage, we sought to convert the noncleaving luteinizing hormone (LH) receptor (LHR) into a cleaved,
121 r cells in that they were 3betaHSD-negative, luteinizing hormone (LH) receptor (LHR)-negative, and pl
123 licular development, including expression of luteinizing hormone (LH) receptor by the granulosa cells
125 l mechanisms play a major role in regulating luteinizing hormone (LH) receptor mRNA expression in the
127 eral motions of individual FLAG-tagged human luteinizing hormone (LH) receptors expressed on CHO cell
128 ave examined their ability to stimulate GnRH/luteinizing hormone (LH) release after peripheral or cen
129 atography was identified as OIF by eliciting luteinizing hormone (LH) release and ovulation in llamas
134 there is no information on the regulation of luteinizing hormone (LH) secretion by NKB or its recepto
135 positive and negative feedback control over luteinizing hormone (LH) secretion during the ovulatory
137 istration of senktide (NK3R agonist) induced luteinizing hormone (LH) secretion in prepubertal and pe
138 the mRNA expression of pituitary LH-RH-R and luteinizing hormone (LH) secretion in three experimental
140 s characterized by the pattern of endogenous luteinizing hormone (LH) secretion on the basis of frequ
147 Although mammalian oocytes ovulated after luteinizing hormone (LH) stimulation can be fertilized a
148 riggers germinal vesicle breakdown after the luteinizing hormone (LH) surge and reentry into the meio
149 have demonstrated that IL-1beta inhibits the luteinizing hormone (LH) surge during the afternoon of p
150 e in the generation of the preovulatory GnRH/luteinizing hormone (LH) surge in the female rodent.
152 ntained in prophase meiotic arrest until the luteinizing hormone (LH) surge induces reentry into the
153 ut not males, to display an estrogen-induced luteinizing hormone (LH) surge is consistent with the hi
154 provides for the timing of the preovulatory luteinizing hormone (LH) surge necessary for ovulation i
155 irregular estrous cycles, lack a coordinated luteinizing hormone (LH) surge on the day of proestrus,
156 to escalating levels of estrogen, express a luteinizing hormone (LH) surge that is prompted by a sur
157 GnRH) surge is a prerequisite signal for the luteinizing hormone (LH) surge that triggers ovulation.
162 tion is induced by the preovulatory surge of luteinizing hormone (LH) that acts on the ovary and trig
163 fully grown follicles, prior to the surge of luteinizing hormone (LH) that triggers meiotic resumptio
164 at clearance rates for glycoproteins such as luteinizing hormone (LH) that undergo regulated release
166 n-deficient mice exhibit increased levels of luteinizing hormone (LH), a pituitary hormone that regul
167 d concentrations of estradiol, progesterone, luteinizing hormone (LH), and follicle-stimulating hormo
168 mones follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and that ovarian steroids exer
169 pin's follicle-stimulating hormone (FSH) and luteinizing hormone (LH), both of which are heterodimers
171 BG), dehydroepiandrosterone sulfate (DHEAS), luteinizing hormone (LH), follicle-stimulating hormone (
175 pins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH), under the control of pulsatile
176 ine, beta-endorphin, and enkephalin) inhibit luteinizing hormone (LH), vasopressin (VP), and oxytocin
179 n by mature Leydig cells in vivo, we treated luteinizing hormone (LH)-stimulated adult male rats and
187 se hamster ovary cells expressing either the luteinizing hormone (LH)/chorionic gonadotropin (CG) or
188 ose demonstrating the presence of functional luteinizing hormone (LH)/hCG receptors in human breast c
189 to the pituitary and the resulting surge of luteinizing hormone (LH); however, the neural circuits t
190 ol <184 pmol/l (50 pg/ml), FSH <10 IU/l, and luteinizing hormone <10 IU/l, was significantly more pre
191 t explained by any deficits in testosterone, luteinizing hormone, or follicle-stimulating hormone con
192 e generated by breeding MMTV-Neu mice with a luteinizing hormone-overexpressing mouse model of ovaria
193 /23), mainly in follicle-stimulating hormone/luteinizing hormone-producing (38%) and null cell (57%)
194 the fasting-associated decrease in overnight luteinizing hormone pulse frequency but had no effect on
195 onic epilepsy was associated with changes in luteinizing hormone pulse frequency, amplitude, and mass
196 high free testosterone, and fewer numbers of luteinizing hormone pulses, but not polycystic-appearing
197 creases in testosterone and the testosterone/luteinizing hormone ratio were detected in men watching
198 t study investigated regulation of the human luteinizing hormone receptor (hLHR) gene by histone deac
200 n hormones to their cognate human receptors (luteinizing hormone receptor (LHR) and thyroid-stimulati
201 n A (TSA), induces derepression of the human luteinizing hormone receptor (LHR) gene by de-recruitmen
203 ously demonstrated that transcription of the luteinizing hormone receptor (LHR) gene is subject to re
205 the past decade, however, the expression of luteinizing hormone receptor (LHR) has also been reporte
207 utant can inhibit signaling to G(s) from the luteinizing hormone receptor by 97% and from the calcito
209 s in the HinRs and the interhelical loops of luteinizing hormone receptor/follicle stimulating hormon
210 erize with its closely related receptor, the luteinizing hormone receptor; this association may have
211 ollicular differentiation markers, including luteinizing-hormone receptor (LHR), inhibin-alpha, micro
212 PD-PALM of two functionally defined mutant luteinizing hormone receptors (LHRs), a ligand-binding d
213 as well as human chorionic gonadotropin and luteinizing hormone receptors on male breast tissue, may
215 2) priming completely blocks hormone-induced luteinizing hormone release and partially inhibits hormo
216 series induced a much prolonged increase of luteinizing hormone release compared to KP10 and increas
217 , and screened for duration of inhibition of luteinizing hormone release in a castrated male rat assa
221 n of prostaglandin E2, which then stimulates luteinizing hormone releasing hormone (LHRH) neurons to
222 dy single-chain variable fragment (scFv) and luteinizing hormone releasing hormone (LHRH) peptide, re
225 n releasing hormone-1 [GnRH-1, also known as luteinizing hormone releasing hormone (LHRH)] neurons ca
228 ombesin (AN-215), somatostatin (AN-238), and luteinizing hormone-releasing hormone (AN-207) consisted
230 Previously, we have shown that two types of luteinizing hormone-releasing hormone (LHRH) -like neuro
231 The effects of depot formulations of the luteinizing hormone-releasing hormone (LHRH) agonist Dec
233 orticotropic hormone (ACTH) and hypothalamic luteinizing hormone-releasing hormone (LHRH) agonist, [D
235 the recent developments on BPH therapy with luteinizing hormone-releasing hormone (LHRH) antagonist
236 tance and (5) a modified synthetic analog of luteinizing hormone-releasing hormone (LHRH) as a target
240 estigate the mechanism by which Mn2+ induces luteinizing hormone-releasing hormone (LHRH) secretion f
241 s by which the neuroendocrine brain controls luteinizing hormone-releasing hormone (LHRH) secretion.
243 large doses of Cetrorelix, an antagonist of luteinizing hormone-releasing hormone (LHRH), reduces le
244 naling pathway that prompts the secretion of luteinizing hormone-releasing hormone (LHRH), the neurop
247 ng afferent pathways to neurons synthesizing luteinizing hormone-releasing hormone (LHRH, also known
249 itive tumors also received letrozole (plus a luteinizing hormone-releasing hormone [LHRH] agonist if
250 diation plus immediate androgen suppression (luteinizing hormone-releasing hormone [LHRH] agonist), w
251 steroid ablation using leuprolide acetate, a luteinizing hormone-releasing hormone agonist (LHRHa), i
253 AST, which was defined as 6 months of both a luteinizing hormone-releasing hormone agonist and an ant
254 ts receiving combined androgen blockade with luteinizing hormone-releasing hormone agonist and bicalu
255 les, followed by total androgen suppression (luteinizing hormone-releasing hormone agonist plus bical
256 tients were randomized soon after initiating luteinizing hormone-releasing hormone agonist with antia
257 n deprivation (AD) to cixutumumab added to a luteinizing hormone-releasing hormone agonist with bical
258 S; two injections of every-3-months depot of luteinizing hormone-releasing hormone agonist) to primar
259 Patients were randomly assigned 2:1 to a luteinizing hormone-releasing hormone agonist, bicalutam
261 ; and three, when chemical suppression using luteinizing hormone-releasing hormone agonists is the ch
262 of 5 ng per milliliter or higher received a luteinizing hormone-releasing hormone analogue and an an
264 s monotherapy or with adjuvant castration or luteinizing hormone-releasing hormone superagonists to b
266 k suggests that cytotoxic peptide analogs of luteinizing hormone-releasing hormone, somatostatin, and
267 ne and metabolic variables were measured and luteinizing hormone sampled over 8 hours on days 2 to 5
268 hormone-secreting (GH-secreting) GH3 cells, luteinizing hormone-secreting (LH-secreting) LbetaT2 cel
269 for estradiol-mediated suppression of tonic luteinizing hormone secretion (an indirect measure of Gn
274 rs in GnIH-ir nuclei, and GnIH inhibition of luteinizing hormone secretion indicate the discovery of
275 stent with a role in regulating preovulatory luteinizing hormone secretion, rostral projections from
276 cute seizures induced timing irregularity in luteinizing hormone secretion, whereas chronic epilepsy
277 ted a robust GnRH discharge, as reflected by luteinizing hormone secretion, which was abolished by pr
281 otein increased >10-fold after the ovulatory luteinizing hormone surge in wild-type but not PRKO mice
282 t in the ovary for extended periods before a luteinizing hormone surge induces entry into the first m
284 losa cells of periovulatory follicles by the luteinizing hormone surge through a progesterone recepto
286 ein alters the amplitude of the preovulatory luteinizing hormone surge, likely by perturbing GnRH rel
287 n several hours after the ovulation-inducing luteinizing hormone surge, whereas they undergo differen
288 kisspeptin is involved in generation of the luteinizing hormone surge, which is required for ovulati
289 d by the puberty-triggering and preovulatory luteinizing hormone surge-mediating peptide, kisspeptin.
294 ens, disrupted reproductive cycles, and high luteinizing hormone, the latter reflecting increased gon
296 nts with abnormal levels of testosterone and luteinizing hormone was less pronounced-57% and 21%, res
297 estradiol, total and free testosterone, and luteinizing hormone were higher by 5.26% (95% CI: 1.27%,
298 ic antigen, thyroid stimulating hormone, and luteinizing hormone) were printed in an array format ont
299 tes pituitary synthesis of a large amount of luteinizing hormone, which is required for ovulation.
300 We used transgenic mice that overexpress luteinizing hormone with subsequent ovarian hyperstimula
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。